Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | September 20, 2023 09:06am

Gainers

  • Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 70.6% to $5.29 during Wednesday's pre-market session. The company's market cap stands at $6.5 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 53.94% to $0.81. The market value of their outstanding shares is at $1.6 million.
  • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock increased by 52.68% to $0.89. The market value of their outstanding shares is at $5.2 million.
  • Histogen (NASDAQ:HSTO) shares increased by 29.93% to $0.51. The market value of their outstanding shares is at $2.1 million.
  • MSP Recovery (NASDAQ:LIFW) shares rose 28.12% to $0.12. The market value of their outstanding shares is at $39.9 million.
  • Exscientia (NASDAQ:EXAI) shares increased by 23.12% to $6.23. The market value of their outstanding shares is at $774.0 million.

Losers

  • Seelos Therapeutics (NASDAQ:SEEL) stock decreased by 65.6% to $0.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $44.0 million.
  • ARS Pharmaceuticals (NASDAQ:SPRY) shares decreased by 54.58% to $3.0. The company's market cap stands at $286.7 million.
  • Elutia (NASDAQ:ELUT) stock fell 15.76% to $1.39. The company's market cap stands at $22.5 million.
  • Heart Test Laboratories (NASDAQ:HSCS) stock fell 13.64% to $0.38. The market value of their outstanding shares is at $4.1 million. The company's, Q1 earnings came out 4 days ago.
  • Regulus Therapeutics (NASDAQ:RGLS) shares declined by 12.13% to $1.45. The market value of their outstanding shares is at $28.2 million.
  • Akili (NASDAQ:AKLI) shares fell 12.13% to $0.65. The company's market cap stands at $50.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKLI BJDX ELUT EXAI FRTX HSCS HSTO LIFW RGLS RNAZ SEEL SPRY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist